Search research articles
Contact Us
Filters
Showing results (1-10 of 120) with videos related to
Page
of 12
Sort By:
Critical Reviews in Oncogenesis
|
February 27, 2008
New doctorial cancer research: germline genetic alterations affecting CDKN2A, MDM2, and CDKN1A in melanoma and breast cancer patients
Stian Knappskog
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 1, 2012
Re: Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis
Stian Knappskog
Oncotarget
|
March 26, 2011
MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk
Stian Knappskog, Per E Lønning
Transcription
|
January 11, 2012
Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk
Stian Knappskog, Per E Lønning
Expert Opinion on Therapeutic Targets
|
February 9, 2012
P53 and its molecular basis to chemoresistance in breast cancer
Stian Knappskog, Per Eystein Lønning
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists
|
April 30, 2013
MDM2 SNP309 and risk of endometrial cancer
Stian Knappskog, Per Eystein Lønning
JCO Precision Oncology
|
April 16, 2026
<i>BRCA1</i> Methylation in Circulating Free DNA: A Constitutional Matter?
Per Eystein Lønning, Stian Knappskog
Clinical Epigenetics
|
October 24, 2018
BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?
Per Eystein Lønning, Stian Knappskog
Breast Cancer Research : BCR
|
November 8, 2012
Chemosensitivity and p53; new tricks by an old dog
Per E Lønning, Stian Knappskog
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 27, 2014
MDM2 SNP309 and risk of endometrial cancer
Stian Knappskog, Per Eystein Lønning
Page
of 12
Search research articles
Search
Showing results (1-10 of 120) with videos related to
Sort By:
Page
of 12
Critical Reviews in Oncogenesis
|
February 27, 2008
New doctorial cancer research: germline genetic alterations affecting CDKN2A, MDM2, and CDKN1A in melanoma and breast cancer patients
Stian Knappskog
International Journal of Urology : Official Journal of the Japanese Urological Association
|
August 1, 2012
Re: Murine double minute 2 promoter SNP309 polymorphism and prostate cancer risk: a meta-analysis
Stian Knappskog
Oncotarget
|
March 26, 2011
MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk
Stian Knappskog, Per E Lønning
Transcription
|
January 11, 2012
Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk
Stian Knappskog, Per E Lønning
Expert Opinion on Therapeutic Targets
|
February 9, 2012
P53 and its molecular basis to chemoresistance in breast cancer
Stian Knappskog, Per Eystein Lønning
Polish Journal of Pathology : Official Journal of the Polish Society of Pathologists
|
April 30, 2013
MDM2 SNP309 and risk of endometrial cancer
Stian Knappskog, Per Eystein Lønning
JCO Precision Oncology
|
April 16, 2026
<i>BRCA1</i> Methylation in Circulating Free DNA: A Constitutional Matter?
Per Eystein Lønning, Stian Knappskog
Clinical Epigenetics
|
October 24, 2018
BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?
Per Eystein Lønning, Stian Knappskog
Breast Cancer Research : BCR
|
November 8, 2012
Chemosensitivity and p53; new tricks by an old dog
Per E Lønning, Stian Knappskog
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
June 27, 2014
MDM2 SNP309 and risk of endometrial cancer
Stian Knappskog, Per Eystein Lønning
Page
of 12